Ingevity Cash Flow Statement
NYSE: NGVTIndustrialsMajor ChemicalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ingevity free cash flow
In fiscal 2025, Ingevity generated $331.2 million of operating cash flow and spent $57.7 million on capital expenditures. That left free cash flow of $273.5 million, a free-cash-flow margin of 23.4% of revenue. Free cash flow was up 436.3% from the prior year's $51.0 million.
Ingevity returned $56.3 million to shareholders through share repurchases, equal to 21% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Ingevity cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -167.10M | -430.30M | -5.40M | 211.60M | 118.10M | 181.40M | 183.70M | 181.80M | 145.20M | 44.40M |
| Net Income growth (YoY) | — | — | -102.55% | +79.17% | -34.90% | -1.25% | +1.05% | +25.21% | +227.03% | -47.33% |
| Depreciation & Amortization | 106.40M | 108.30M | 122.80M | 108.80M | 109.90M | 100.20M | 85.00M | 57.00M | 40.40M | 38.80M |
| Stock-Based Compensation | 18.30M | 11.90M | 10.60M | 16.10M | 12.30M | 8.40M | 12.30M | 12.50M | 10.10M | 4.70M |
| Change in Working Capital | 37.00M | 54.80M | 17.60M | -63.10M | -60.70M | 36.60M | -23.90M | -31.00M | -7.90M | -1.90M |
| Operating Cash Flow | 331.20M | 128.60M | 205.10M | 313.40M | 293.30M | 352.40M | 275.70M | 252.00M | 174.30M | 127.90M |
| Capital Expenditures | -57.70M | -77.60M | -109.80M | -142.50M | -103.80M | -82.10M | -114.80M | -93.90M | -52.60M | -56.70M |
| Investing Cash Flow | -57.50M | -79.50M | -77.30M | -551.90M | -138.60M | -110.60M | -658.30M | -414.40M | -58.60M | -126.40M |
| Share Repurchases | -56.30M | 0 | -92.10M | -145.20M | -109.40M | -88.00M | -6.40M | -47.40M | -6.60M | 0 |
| Debt Issued | 291.30M | 404.50M | 376.30M | 1.16B | 0 | 550.00M | 375.00M | 300.00M | 75.00M | 300.00M |
| Debt Repaid | — | 0 | 0 | -628.10M | -23.40M | -389.10M | -122.50M | 0 | 0 | 0 |
| Financing Cash Flow | -252.20M | -70.20M | -99.90M | 48.10M | -133.10M | -50.20M | 369.20M | 153.70M | -57.80M | -3.40M |
| Net Change in Cash | 26.00M | -25.30M | 27.60M | -196.40M | 19.90M | 193.80M | -13.20M | -10.10M | 57.40M | -1.50M |
| Free Cash Flow | 273.50M | 51.00M | 95.30M | 170.90M | 189.50M | 270.30M | 160.90M | 158.10M | 121.70M | 71.20M |
This table shows 10 annual periods of Ingevity's cash flow statement, from FY 2025 back to FY 2016, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow NGVT's reporting calendar. What is a cash flow statement?